Novartis AG
USD157.59
+2.18 (+1.40%)
CEO
Vas Narasimhan
IPO Date
1996-11-07
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
CH
Open
$156.14
Prev. Close
$155.41
Day Low
$155.79
Day High
$157.68
52W Low
$112.34
52W High
$170.46
Market Cap
$300.70B
Volume
2.18M
| 16.5 |
| 31 Dec 2023 | FY | 73.3% | 31.8% | 31.8% | 14.9% | 0.56 | 1.16 | 14.2 |
| 31 Dec 2022 | FY | 73.4% | 16.0% | 11.7% | 5.9% | 0.47 | 1.29 | 28.3 |
| 31 Dec 2021 | FY | 73.3% | 54.6% | 35.5% | 18.2% | 0.46 | 1.51 | 8.2 |
| 31 Dec 2020 | FY | 69.7% | 16.2% | 14.3% | 6.3% | 0.67 | 0.90 | 26.7 |
| 31 Dec 2019 | FY | 70.4% | 24.1% | 21.1% | 9.9% | 0.53 | 1.04 | 18.5 |
| 31 Dec 2018 | FY | 68.5% | 27.4% | 16.0% | 8.7% | 0.41 | 1.20 | 13.9 |
| 31 Dec 2017 | FY | 68.6% | 17.7% | 10.4% | 5.8% | 0.38 | 1.21 | 22.7 |
| 31 Dec 2016 | FY | 64.6% | 13.6% | 9.0% | 5.2% | 0.32 | 1.12 | 22.8 |
| 27.2 |
| 30 Sept 2025 | Q3 | 75.4% | 27.4% | 8.9% | 3.7% | 0.72 | 0.88 | 15.6 |
| 30 Jun 2025 | Q2 | 77.6% | 27.2% | 9.6% | 3.9% | 0.78 | 0.82 | 14.6 |
| 30 Mar 2025 | Q1 | 76.3% | 26.5% | 9.4% | 3.6% | 0.81 | 0.79 | 15.1 |
| 31 Dec 2024 | Q4 | 75.5% | 20.8% | 6.4% | 2.8% | 0.71 | 1.04 | 17.2 |
| 30 Sept 2024 | Q3 | 75.4% | 24.2% | 7.4% | 3.1% | 0.74 | 1.11 | 18.1 |
| 30 Jun 2024 | Q2 | 75.3% | 25.2% | 7.8% | 3.3% | 0.69 | 0.93 | 17.0 |
| 31 Mar 2024 | Q1 | 74.5% | 22.2% | 6.8% | 2.8% | 0.69 | 0.90 | 18.0 |
| 31 Dec 2023 | Q4 | 74.3% | 72.0% | 18.2% | 8.5% | 0.56 | 1.16 | 6.1 |